← All stocks

AGIOS PHARMACEUTICALS, INC.

AGIO Net buying
CIK 0001439222 #2036 in the set updated 17 Sep 2026
Bought (120 mo)
$101.96M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$116.82M
$5.94M on a plan · $79.87M straight out of an exercise
Sold at will
$31.02M
117 of 411 sales
Net
−$14.86M
+$70.94M against sales at will

By person

33 insiders · 430 transactions
6.6×

Brian Goff holds 6.6 times base salary in stock. $5.62M of shares against $846.86K in salary for 2025.

Salary from the company's own proxy. The shares are what Brian Goff last reported holding, valued at $30.48, the price Common stock was last bought or sold at on the open market here, on 4 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CELGENE CORP /DE/ entity
10% owner
$69.53M (2)
+$69.53M
2,486,157
4.16%
$75.78M
+101.8%
Schenkein David P
Director
$249.98K (1)
$43.84M (63) scheduled
−$43.59M
397,014
0.6650%
$12.10M
+45.8%
Celgene European Investment Co LLC entity
10% owner
$30.92M (1)
+$30.92M
5,867,279
9.83%
$178.83M
+11.9%
NELSEN ROBERT
Director
$20.75M (15)
−$20.75M
109,230
0.1830%
$3.33M
−79.3%
Bowden Christopher
Chief Medical Officer
$12.62M (37) scheduled
−$12.62M
15,487
0.0259%
$472.04K
+1,086%
Biller Scott
Chief Scientific Officer
$12.34M (64) scheduled
−$12.34M
86,788
0.1454%
$2.65M
+16.4%
Goff Brian
Chief Executive Officer
$5.41M (19) scheduled
−$5.41M
184,508
0.3090%
$5.62M
Hoerter Steven L.
Chief Commercial Officer
$3.75M (10) scheduled
−$3.75M
10,941
0.0183%
$333.48K
Gheuens Sarah
Chief Medical Officer
$2.85M (24) scheduled
−$2.85M
54,645
0.0915%
$1.67M
+691.4%
Cantley Lewis Clayton Jr.
Director
$2.59M (66)
−$2.59M
158,990
0.2663%
$4.85M
−22.1%
Foster-Cheek Kaye I
Director
$2.24M (8) scheduled
−$2.24M
10,284
0.0172%
$313.46K
Burns James William
Chief Legal Officer
$2.10M (19) scheduled
−$2.10M
49,306
0.0826%
$1.50M
+406.2%
MARAGANORE JOHN
Director
$2.00M (3)
−$2.00M
30,028
0.0503%
$915.25K
−53.0%
Ballal Rahul D.
Director
$1.12M (5) scheduled
−$1.12M
15,230
0.0255%
$464.21K
Washburn Theodore James Jr.
Principal Accounting Officer
$1.06M (24)
−$1.06M
868
0.0015%
$26.46K
−71.1%
Jones Cecilia
Chief Financial Officer
$895.71K (15) scheduled
−$895.71K
54,998
0.0921%
$1.68M
+2,216%
Alenson Carman
Principal Accounting Officer
$773.19K (12)
−$773.19K
0
0.0000%
$0.00
−100.0%
Milanova Tsveta
Chief Commercial Officer
$741.86K (11) scheduled
−$741.86K
46,829
0.0784%
$1.43M
Miles Darrin
Chief Commercial Officer
$321.70K (3)
−$321.70K
7,209
0.0121%
$219.73K
+16.5%
Viswanadhan Krishnan
Chief Strategy and Operations
$184.97K (2) scheduled
−$184.97K
10,282
0.0172%
$313.40K
FOUSE JACQUALYN A
Director
$1.25M (1)
$1.14M (5) scheduled
+$112.27K
154,156
0.2582%
$4.70M
Scadden David
Director
$16.69K (1)
$98.22K (6) scheduled
−$81.54K
20,419
0.0342%
$622.37K
+5,404%
Hirsch Andrew
Chief Financial Officer
24,272
0.0407%
$739.81K
+808,967%
Biller Jonathan
Chief Financial Officer
22,953
0.0384%
$699.61K
+2,665%
Ho Maykin
Director
19,848
0.0332%
$604.97K
Car Bruce
Chief Scientific Officer
16,752
0.0281%
$510.60K
Smith Cynthia
Director
15,230
0.0255%
$464.21K
Owen Adams Catherine
Director
10,865
0.0182%
$331.17K
CAPELLO JEFFREY D
Director
10,865
0.0182%
$331.17K
Poddar Richa
Chief Commercial Officer
8,508
0.0143%
$259.32K
+1,112%
Clancy Paul J
Director
6,549
0.0110%
$199.61K
CLARK IAN T
Director
6,549
0.0110%
$199.61K
Backstrom Jay T.
Director
1,447
0.0024%
$44.10K
Insider
Date
Role
Action
Shares
Price
Amount
Gheuens Sarah
1 Jul 2026
Chief Medical Officer
Sold after exercise
4,007
$37.56
$150.50K
Goff Brian
2 Apr 2026
Chief Executive Officer
Sold after exercise
6,596
$34.71
$228.95K
Goff Brian
2 Apr 2026
Chief Executive Officer
Sold after exercise
12,472
$34.71
$432.90K
Viswanadhan Krishnan
2 Apr 2026
Chief Corp Dev & Strategy
Sold after exercise
2,959
$34.71
$102.71K
Milanova Tsveta
2 Apr 2026
Chief Commercial Officer
Sold after exercise
3,262
$34.71
$113.22K
Jones Cecilia
2 Apr 2026
Chief Financial Officer
Sold after exercise
3,141
$34.71
$109.02K
Gheuens Sarah
2 Apr 2026
Chief Medical Officer
Sold after exercise
2,940
$34.71
$102.05K
Burns James William
2 Apr 2026
Chief Legal Officer
Sold after exercise
3,280
$34.71
$113.85K
Viswanadhan Krishnan
5 Mar 2026
Chief Corp Dev & Strategy
Sold after exercise
2,959
$27.80
$82.26K
Washburn Theodore James Jr.
2 Mar 2026
Principal Accounting Officer
Sold after exercise
798
$28.96
$23.11K
Washburn Theodore James Jr.
2 Mar 2026
Principal Accounting Officer
Sold after exercise
727
$28.96
$21.05K
Washburn Theodore James Jr.
2 Mar 2026
Principal Accounting Officer
Sold after exercise
698
$28.96
$20.21K
Milanova Tsveta
2 Mar 2026
Chief Commercial Officer
Sold after exercise
1,187
$28.96
$34.38K
Milanova Tsveta
2 Mar 2026
Chief Commercial Officer
Sold after exercise
1,681
$28.96
$48.68K
Jones Cecilia
2 Mar 2026
Chief Financial Officer
Sold after exercise
1,573
$28.96
$45.55K
Jones Cecilia
2 Mar 2026
Chief Financial Officer
Sold after exercise
1,187
$28.96
$34.38K
Jones Cecilia
2 Mar 2026
Chief Financial Officer
Sold after exercise
1,681
$28.96
$48.68K
Jones Cecilia
2 Mar 2026
Chief Financial Officer
Sold after exercise
594
$28.96
$17.20K
Gheuens Sarah
2 Mar 2026
Chief Medical Officer
Sold after exercise
1,187
$28.96
$34.38K
Gheuens Sarah
2 Mar 2026
Chief Medical Officer
Sold after exercise
1,681
$28.96
$48.68K
Gheuens Sarah
2 Mar 2026
Chief Medical Officer
Sold after exercise
1,187
$28.96
$34.38K
Burns James William
2 Mar 2026
Chief Legal Officer
Sold after exercise
1,163
$28.96
$33.68K
Burns James William
2 Mar 2026
Chief Legal Officer
Sold after exercise
1,187
$28.96
$34.38K
Burns James William
2 Mar 2026
Chief Legal Officer
Sold after exercise
1,681
$28.96
$48.68K
Burns James William
2 Mar 2026
Chief Legal Officer
Sold after exercise
1,187
$28.96
$34.38K
Goff Brian
2 Mar 2026
Chief Executive Officer
Sold after exercise
5,918
$28.96
$171.39K
Goff Brian
2 Mar 2026
Chief Executive Officer
Sold after exercise
8,267
$28.96
$239.41K
Goff Brian
2 Mar 2026
Chief Executive Officer
Sold after exercise
3,870
$28.96
$112.08K
Milanova Tsveta
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,872
$27.02
$77.60K
Jones Cecilia
30 Dec 2025
Chief Financial Officer
Sold after exercise
2,932
$27.09
$79.43K
Milanova Tsveta
30 Dec 2025
Chief Commercial Officer
Sold after exercise
2,932
$27.09
$79.43K
Gheuens Sarah
30 Dec 2025
Chief Medical Officer
Sold after exercise
2,932
$27.09
$79.43K
Goff Brian
30 Dec 2025
Chief Executive Officer
Sold after exercise
6,230
$27.09
$168.77K
Goff Brian
30 Dec 2025
Chief Executive Officer
Sold after exercise
12,473
$27.09
$337.89K
Burns James William
30 Dec 2025
Chief Legal Officer
Sold after exercise
2,932
$27.09
$79.43K
Scadden David
12 Nov 2025
Director
Sold after exercise
200
$43.84
$8.77K
Gheuens Sarah
11 Nov 2025
Chief Medical Officer
Sold after exercise
2,454
$43.78
$107.44K
Gheuens Sarah
30 Oct 2025
Chief Medical Officer
Sold after exercise
200
$43.81
$8.76K
Gheuens Sarah
27 Oct 2025
Chief Medical Officer
Sold after exercise
3,302
$43.92
$145.02K
Scadden David
8 Oct 2025
Director
Sold after exercise
200
$41.00
$8.20K
Scadden David
30 Sep 2025
Director
Sold after exercise
200
$40.00
$8.00K
Jones Cecilia
26 Sep 2025
Chief Financial Officer
Sold after exercise
3,651
$36.77
$134.25K
Scadden David
27 Aug 2025
Director
Sold after exercise
200
$40.00
$8.00K
Goff Brian
8 Aug 2025
Chief Executive Officer
Sold after exercise
11,085
$36.67
$406.49K
Scadden David
10 Jul 2025
Director
Sold after exercise
1,400
$40.00
$56.00K
Gheuens Sarah
9 Jul 2025
Chief Medical Officer
Sold after exercise
847
$38.76
$32.83K
Gheuens Sarah
9 Jul 2025
Chief Medical Officer
Sold after exercise
11,067
$37.93
$419.77K
Gheuens Sarah
1 Jul 2025
Chief Medical Officer
Sold after exercise
4,091
$34.17
$139.79K
Goff Brian
24 Jun 2025
Chief Executive Officer
Sold after exercise
6,229
$33.54
$208.92K
Goff Brian
24 Jun 2025
Chief Executive Officer
Sold after exercise
12,471
$33.54
$418.28K
Milanova Tsveta
24 Jun 2025
Chief Commercial Officer
Sold after exercise
2,770
$33.54
$92.91K
Jones Cecilia
24 Jun 2025
Chief Financial Officer
Sold after exercise
1,780
$33.54
$59.70K
Gheuens Sarah
24 Jun 2025
Chief Medical Officer
Sold after exercise
2,909
$33.54
$97.57K
Burns James William
24 Jun 2025
Chief Legal Officer
Sold after exercise
2,799
$33.54
$93.88K
Washburn Theodore James Jr.
3 Mar 2025
Principal Accounting Officer
Sold after exercise
727
$35.54
$25.84K
Washburn Theodore James Jr.
3 Mar 2025
Principal Accounting Officer
Sold after exercise
697
$35.54
$24.77K
Washburn Theodore James Jr.
3 Mar 2025
Principal Accounting Officer
Sold after exercise
231
$35.54
$8.21K
Scadden David
11 Dec 2024
Director
Sold after exercise
200
$46.28
$9.26K
Ballal Rahul D.
8 Nov 2024
Director
Sold after exercise
1,500
$59.21
$88.82K
Ballal Rahul D.
8 Nov 2024
Director
Sold after exercise
4,929
$58.57
$288.69K
Ballal Rahul D.
8 Nov 2024
Director
Sold after exercise
3,571
$57.24
$204.40K
Ballal Rahul D.
7 Nov 2024
Director
Sold after exercise
1,868
$54.41
$101.64K
Ballal Rahul D.
7 Nov 2024
Director
Sold after exercise
8,132
$53.32
$433.60K
Jones Cecilia
26 Sep 2024
Chief Financial Officer
Sold after exercise
2,542
$49.03
$124.63K
Goff Brian
8 Aug 2024
Chief Executive Officer
Sold after exercise
11,091
$42.75
$474.14K
Gheuens Sarah
1 Jul 2024
Chief Medical Officer
Sold after exercise
3,705
$43.85
$162.46K
Goff Brian
5 Jun 2024
Chief Executive Officer
Sold after exercise
12,115
$48.84
$591.70K
Schenkein David P
27 Feb 2024
Director
Sold after exercise
57,471
$34.89
$2.01M
Schenkein David P
27 Feb 2024
Director
Sold after exercise
11,858
$33.60
$398.43K
Schenkein David P
26 Feb 2024
Director
Sold after exercise
20,411
$33.19
$677.44K
Schenkein David P
23 Feb 2024
Director
Sold after exercise
47,731
$33.05
$1.58M
Foster-Cheek Kaye I
9 Aug 2023
Director
Sold after exercise
25,000
$25.96
$648.89K
Goff Brian
8 Aug 2023
Chief Executive Officer
Sold after exercise
10,178
$25.48
$259.34K
Washburn Theodore James Jr.
1 Aug 2023
Principal Accounting Officer
Sold after exercise
1,232
$26.26
$32.35K
Schenkein David P
3 Apr 2023
Director
Sold after exercise
16,363
$22.85
$373.89K
Schenkein David P
27 Mar 2023
Director
Sold after exercise
20,000
$22.15
$443.00K
Schenkein David P
13 Mar 2023
Director
Sold after exercise
1,667
$22.72
$37.87K
Schenkein David P
13 Mar 2023
Director
Sold after exercise
18,333
$22.47
$411.94K
Schenkein David P
27 Feb 2023
Director
Sold after exercise
20,000
$25.37
$507.40K
Washburn Theodore James Jr.
14 Feb 2023
Principal Accounting Officer
Sold after exercise
504
$28.59
$14.41K
Schenkein David P
13 Feb 2023
Director
Sold after exercise
20,000
$28.62
$572.40K
Schenkein David P
30 Jan 2023
Director
Sold after exercise
3,300
$29.88
$98.60K
Schenkein David P
30 Jan 2023
Director
Sold after exercise
16,700
$29.22
$487.97K
Schenkein David P
17 Jan 2023
Director
Sold after exercise
1,034
$29.49
$30.49K
Schenkein David P
17 Jan 2023
Director
Sold after exercise
18,966
$28.82
$546.60K
Washburn Theodore James Jr.
14 Feb 2022
Principal Accounting Officer
Sold after exercise
504
$31.25
$15.75K
Alenson Carman
21 Jun 2021
Principal Accounting Officer
Sold after exercise
1,777
$61.61
$109.48K
Bowden Christopher
18 Jun 2021
Chief Medical Officer
Sold after exercise
48,493
$60.11
$2.91M
Bowden Christopher
17 Jun 2021
Chief Medical Officer
Sold after exercise
2,502
$60.02
$150.17K
Bowden Christopher
10 Jun 2021
Chief Medical Officer
Sold after exercise
20,853
$60.06
$1.25M
Bowden Christopher
9 Jun 2021
Chief Medical Officer
Sold after exercise
7,149
$60.16
$430.12K
Bowden Christopher
8 Jun 2021
Chief Medical Officer
Sold after exercise
6,675
$60.07
$400.94K
Bowden Christopher
7 Jun 2021
Chief Medical Officer
Sold after exercise
4,268
$60.04
$256.23K
Bowden Christopher
20 Apr 2021
Chief Medical Officer
Sold after exercise
14,401
$55.11
$793.58K
Bowden Christopher
19 Apr 2021
Chief Medical Officer
Sold after exercise
3,210
$55.16
$177.05K
Bowden Christopher
20 May 2020
Chief Medical Officer
Sold after exercise
3,583
$50.01
$179.20K
Bowden Christopher
13 Feb 2020
Chief Medical Officer
Sold after exercise
7,100
$50.16
$356.11K
Bowden Christopher
11 Feb 2020
Chief Medical Officer
Sold after exercise
621
$50.02
$31.06K
Bowden Christopher
4 Feb 2020
Chief Medical Officer
Sold after exercise
35,447
$50.10
$1.78M
Bowden Christopher
4 Feb 2020
Chief Medical Officer
Sold after exercise
14,191
$50.03
$709.96K
Biller Scott
5 Apr 2019
Chief Scientific Officer
Sold after exercise
599
$68.12
$40.80K
Biller Scott
5 Apr 2019
Chief Scientific Officer
Sold after exercise
2,401
$67.61
$162.33K
Bowden Christopher
1 Apr 2019
Chief Medical Officer
Sold after exercise
100
$68.72
$6.87K
Bowden Christopher
1 Apr 2019
Chief Medical Officer
Sold after exercise
1,500
$68.09
$102.14K
Bowden Christopher
1 Apr 2019
Chief Medical Officer
Sold after exercise
2,546
$66.85
$170.20K
Bowden Christopher
1 Apr 2019
Chief Medical Officer
Sold after exercise
5,854
$66.03
$386.54K
Bowden Christopher
15 Mar 2019
Chief Medical Officer
Sold after exercise
1,300
$64.64
$84.03K
Bowden Christopher
15 Mar 2019
Chief Medical Officer
Sold after exercise
8,700
$64.09
$557.58K
Biller Scott
5 Mar 2019
Chief Scientific Officer
Sold after exercise
200
$68.22
$13.64K
Biller Scott
5 Mar 2019
Chief Scientific Officer
Sold after exercise
2,600
$67.73
$176.10K
Biller Scott
5 Mar 2019
Chief Scientific Officer
Sold after exercise
200
$66.45
$13.29K
Hoerter Steven L.
4 Mar 2019
Chief Commercial Officer
Sold after exercise
5,000
$68.00
$340.00K
Hoerter Steven L.
1 Mar 2019
Chief Commercial Officer
Sold after exercise
5,000
$66.01
$330.05K
Biller Scott
27 Feb 2019
Chief Scientific Officer
Sold after exercise
9,000
$65.00
$585.00K
Biller Scott
5 Nov 2018
Chief Scientific Officer
Sold after exercise
100
$71.42
$7.14K
Biller Scott
5 Nov 2018
Chief Scientific Officer
Sold after exercise
700
$70.23
$49.16K
Biller Scott
5 Nov 2018
Chief Scientific Officer
Sold after exercise
2,200
$69.44
$152.77K
Biller Scott
5 Oct 2018
Chief Scientific Officer
Sold after exercise
21
$71.77
$1.51K
Biller Scott
5 Oct 2018
Chief Scientific Officer
Sold after exercise
1,100
$71.05
$78.16K
Biller Scott
5 Oct 2018
Chief Scientific Officer
Sold after exercise
979
$69.47
$68.01K
Biller Scott
5 Oct 2018
Chief Scientific Officer
Sold after exercise
900
$68.56
$61.70K
Biller Scott
5 Sep 2018
Chief Scientific Officer
Sold after exercise
100
$84.38
$8.44K
Biller Scott
5 Sep 2018
Chief Scientific Officer
Sold after exercise
2,260
$83.17
$187.96K
Biller Scott
5 Sep 2018
Chief Scientific Officer
Sold after exercise
640
$82.52
$52.81K
Alenson Carman
5 Sep 2018
Principal Accounting Officer
Sold after exercise
312
$83.00
$25.90K
Bowden Christopher
30 Aug 2018
Chief Medical Officer
Sold after exercise
1,700
$80.03
$136.05K
Bowden Christopher
29 Aug 2018
Chief Medical Officer
Sold after exercise
300
$80.00
$24.00K
Hoerter Steven L.
24 Aug 2018
Chief Commercial Officer
Sold after exercise
2,050
$74.92
$153.59K
Biller Scott
6 Aug 2018
Chief Scientific Officer
Sold after exercise
600
$80.87
$48.52K
Biller Scott
6 Aug 2018
Chief Scientific Officer
Sold after exercise
2,100
$80.15
$168.32K
Biller Scott
6 Aug 2018
Chief Scientific Officer
Sold after exercise
300
$78.32
$23.50K
Hoerter Steven L.
25 Jul 2018
Chief Commercial Officer
Sold after exercise
2,050
$84.58
$173.39K
Bowden Christopher
10 Jul 2018
Chief Medical Officer
Sold after exercise
800
$87.26
$69.81K
Bowden Christopher
10 Jul 2018
Chief Medical Officer
Sold after exercise
1,200
$86.42
$103.70K
Alenson Carman
9 Jul 2018
Principal Accounting Officer
Sold after exercise
272
$84.94
$23.10K
Biller Scott
5 Jul 2018
Chief Scientific Officer
Sold after exercise
300
$84.32
$25.30K
Biller Scott
5 Jul 2018
Chief Scientific Officer
Sold after exercise
2,700
$83.41
$225.21K
Hoerter Steven L.
22 Jun 2018
Chief Commercial Officer
Sold after exercise
2,050
$97.58
$200.04K
Foster-Cheek Kaye I
14 Jun 2018
Director
Sold after exercise
839
$94.30
$79.12K
Foster-Cheek Kaye I
14 Jun 2018
Director
Sold after exercise
5,980
$93.78
$560.80K
Foster-Cheek Kaye I
14 Jun 2018
Director
Sold after exercise
2,181
$92.62
$202.00K
Bowden Christopher
12 Jun 2018
Chief Medical Officer
Sold after exercise
200
$93.37
$18.67K
Bowden Christopher
12 Jun 2018
Chief Medical Officer
Sold after exercise
1,800
$92.84
$167.11K
Biller Scott
5 Jun 2018
Chief Scientific Officer
Sold after exercise
939
$94.28
$88.53K
Biller Scott
5 Jun 2018
Chief Scientific Officer
Sold after exercise
1,259
$93.27
$117.43K
Biller Scott
5 Jun 2018
Chief Scientific Officer
Sold after exercise
802
$92.45
$74.14K
Schenkein David P
1 Jun 2018
Chief Executive Officer
Sold after exercise
100
$96.91
$9.69K
Schenkein David P
1 Jun 2018
Chief Executive Officer
Sold after exercise
3,190
$96.40
$307.52K
Schenkein David P
1 Jun 2018
Chief Executive Officer
Sold after exercise
8,200
$95.11
$779.90K
Schenkein David P
1 Jun 2018
Chief Executive Officer
Sold after exercise
1,510
$94.37
$142.50K
Schenkein David P
30 May 2018
Chief Executive Officer
Sold after exercise
45,626
$90.07
$4.11M
Biller Scott
23 May 2018
Chief Scientific Officer
Sold after exercise
15,177
$90.00
$1.37M
Hoerter Steven L.
23 May 2018
Chief Commercial Officer
Sold after exercise
2,050
$85.76
$175.81K
Schenkein David P
23 May 2018
Chief Executive Officer
Sold after exercise
299
$92.03
$27.52K
Schenkein David P
23 May 2018
Chief Executive Officer
Sold after exercise
9,301
$91.60
$851.97K
Schenkein David P
23 May 2018
Chief Executive Officer
Sold after exercise
39,774
$90.11
$3.58M
Bowden Christopher
11 May 2018
Chief Medical Officer
Sold after exercise
1,160
$85.14
$98.76K
Bowden Christopher
11 May 2018
Chief Medical Officer
Sold after exercise
840
$84.81
$71.24K
Bowden Christopher
8 May 2018
Chief Medical Officer
Sold after exercise
2,000
$81.38
$162.76K
Biller Scott
7 May 2018
Chief Scientific Officer
Sold after exercise
3,000
$81.81
$245.43K
Schenkein David P
1 May 2018
Chief Executive Officer
Sold after exercise
100
$84.35
$8.44K
Schenkein David P
1 May 2018
Chief Executive Officer
Sold after exercise
2,814
$83.56
$235.14K
Schenkein David P
1 May 2018
Chief Executive Officer
Sold after exercise
10,086
$82.88
$835.93K
Hoerter Steven L.
23 Apr 2018
Chief Commercial Officer
Sold after exercise
2,050
$85.95
$176.20K
Bowden Christopher
12 Apr 2018
Chief Medical Officer
Sold after exercise
700
$85.68
$59.98K
Showing 250 of 430 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 487
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 47
Sales straight out of an exercise 247
Sales at will 117
Transactions with no price 0
Shares from compensation/vesting 2,814,895
Sales filed before the plan box existed 106
History held since 31 Aug 2016